 | • レポートコード：MRC-IM30313 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年474億ドルであった世界の抗生物質市場規模が2027年には615億ドルに達し、予測期間中、年平均4.4％成長すると予測しています。本調査レポートでは、抗生物質の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、作用機序別（細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、その他）分析、医薬品クラス別（セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、その他）分析、抗菌力スペクトラム別（広域スペクトラム抗生物質、狭域スペクトラム抗生物質）分析、投与経路別（経口、非経口、外用、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Allergan Plc (AbbVie Inc.), Basilea Pharmaceutica AG, GlaxoSmithKline Plc, Johnson & Johnson, Melinta Therapeutics, Merck & Co. Inc., Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Spero Therapeutics,Tetraphase Pharmaceuticalsなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の抗生物質市場規模：作用機序別 - 細胞壁合成阻害剤の市場規模 - タンパク質合成阻害剤の市場規模 - DNA合成阻害剤の市場規模 - RNA合成阻害剤の市場規模 - その他抗生物質の市場規模 ・世界の抗生物質市場規模：医薬品クラス別 - セファロスポリンの市場規模 - ペニシリンの市場規模 - フルオロキノロンの市場規模 - マクロライドの市場規模 - その他抗生物質にの市場規模 ・世界の抗生物質市場規模：抗菌力スペクトラム別 - 広域スペクトラム抗生物質の市場規模 - 狭域スペクトラム抗生物質の市場規模 ・世界の抗生物質市場規模：投与経路別 - 経口抗生物質の市場規模 - 非経口抗生物質の市場規模 - 外用抗生物質の市場規模 - その他抗生物質の市場規模 ・世界の抗生物質市場規模：地域別 - 北米の抗生物質市場規模 - アジアの抗生物質市場規模 - 欧州の抗生物質市場規模 - 中南米の抗生物質市場規模 - 中東・アフリカの抗生物質市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global antibiotics market size reached US$ 47.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.5 Billion by 2027, exhibiting a growth rate (CAGR) of 4.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Antibiotics are a group of medicines, such as penicillin, cephalosporin, fluoroquinolone, etc., that inhibit the growth of microorganisms, prevent the replication of parasites, and reduce serious complications of bacterial infections. They are generally administered orally in the form of pills, liquids, tablets, and capsules. They are also available as sprays, creams, ointments, and lotions, which are applied topically on the skin to treat certain acne and other skin diseases. Moreover, antibiotics can be administered through an injection or intravenously (IV) for severe infections according to the signs and symptoms of the patients.
The growing prevalence of infectious diseases, such as malaria, tuberculosis, pneumonia, and acquired immunodeficiency syndrome (AIDS), along with the easy availability of generic medicines, represents one of the major factors positively influencing the demand for antibiotics. Moreover, the topical application of antibiotics offers reduced potential for systemic absorption and toxicity and minimizes the risk of surgical site infections. Consequently, the rising number of surgical procedures is increasing the sales of antibiotics to prevent incision infection. They can also be utilized in the form of drops for conjunctivitis and acute ear infections. Furthermore, antibiotics are finding extensive application in livestock farming to safeguard animal health and welfare and support food safety. Apart from this, scientists are developing less reactogenic, cell-free vaccines consisting of purified components, inactivated toxins, and proteins. Additionally, several health organizations are entering into strategic partnerships with private companies to deliver new treatments and improve existing drugs.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antibiotics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on action mechanism, drug class, spectrum of activity, route of administration and end user.
Breakup by Action Mechanism:
Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others
Breakup by Drug Class:
Cephalosporin
Penicillin
Fluoroquinolone
Macrolide
Carbapenem
Aminoglycoside
Others
Breakup by Spectrum of Activity:
Broad-Spectrum Antibiotics
Narrow-Spectrum Antibiotics
Breakup by Route of Administration:
Oral
Parenteral
Topical
Others
Breakup by End User:
Hospitals
Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc (AbbVie Inc.), Basilea Pharmaceutica AG, GlaxoSmithKline Plc, Johnson & Johnson, Melinta Therapeutics, Merck & Co. Inc., Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Spero Therapeutics and Tetraphase Pharmaceuticals.
Key Questions Answered in This Report:
How has the global antibiotics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global antibiotics market?
What are the key regional markets?
What is the breakup of the market based on the action mechanism?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the spectrum of activity?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global antibiotics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antibiotics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Action Mechanism
6.1 Cell Wall Synthesis Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Protein Synthesis Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 DNA Synthesis Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 RNA Synthesis Inhibitors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Mycolic Acid Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Cephalosporin
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Penicillin
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Fluoroquinolone
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Macrolide
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Carbapenem
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Aminoglycoside
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Spectrum of Activity
8.1 Broad-Spectrum Antibiotics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Narrow-Spectrum Antibiotics
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Topical
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Allergan Plc (AbbVie Inc.)
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 SWOT Analysis
16.3.2 Basilea Pharmaceutica AG
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 GlaxoSmithKline Plc
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Johnson & Johnson
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Melinta Therapeutics
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Merck & Co. Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Nabriva Therapeutics Plc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Paratek Pharmaceuticals Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Pfizer Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sanofi SA
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Spero Therapeutics
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Tetraphase Pharmaceuticals
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
Figure 2: Global: Antibiotics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antibiotics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antibiotics Market: Breakup by Action Mechanism (in %), 2021
Figure 5: Global: Antibiotics Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Antibiotics Market: Breakup by Spectrum of Activity (in %), 2021
Figure 7: Global: Antibiotics Market: Breakup by Route of Administration (in %), 2021
Figure 8: Global: Antibiotics Market: Breakup by End User (in %), 2021
Figure 9: Global: Antibiotics Market: Breakup by Region (in %), 2021
Figure 10: Global: Antibiotics (Cell Wall Synthesis Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Antibiotics (Cell Wall Synthesis Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Antibiotics (Protein Synthesis Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Antibiotics (Protein Synthesis Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Antibiotics (DNA Synthesis Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Antibiotics (DNA Synthesis Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Antibiotics (RNA Synthesis Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Antibiotics (RNA Synthesis Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Antibiotics (Mycolic Acid Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Antibiotics (Mycolic Acid Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Antibiotics (Other Action Mechanisms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Antibiotics (Other Action Mechanisms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Antibiotics (Cephalosporin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Antibiotics (Cephalosporin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Antibiotics (Penicillin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Antibiotics (Penicillin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Antibiotics (Fluoroquinolone) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Antibiotics (Fluoroquinolone) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Antibiotics (Macrolide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Antibiotics (Macrolide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Antibiotics (Carbapenem) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Antibiotics (Carbapenem) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Antibiotics (Aminoglycoside) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Antibiotics (Aminoglycoside) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Antibiotics (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Antibiotics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Antibiotics (Broad-Spectrum Antibiotics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Antibiotics (Broad-Spectrum Antibiotics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Antibiotics (Narrow-Spectrum Antibiotics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Antibiotics (Narrow-Spectrum Antibiotics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Antibiotics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Antibiotics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Antibiotics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Antibiotics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Antibiotics (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Antibiotics (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Antibiotics (Other Routes of Administration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Antibiotics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Antibiotics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Antibiotics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: Antibiotics (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: Antibiotics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Global: Antibiotics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Global: Antibiotics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: North America: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: North America: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United States: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United States: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Canada: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Canada: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Asia-Pacific: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Asia-Pacific: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: China: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: China: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Japan: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Japan: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: India: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: India: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: South Korea: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: South Korea: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Australia: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Australia: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Indonesia: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Indonesia: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Europe: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Europe: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Germany: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Germany: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: France: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: France: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: United Kingdom: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: United Kingdom: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Italy: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Italy: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Spain: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Spain: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Russia: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Russia: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Others: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Others: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Latin America: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Latin America: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Brazil: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Brazil: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Mexico: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Mexico: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Others: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Others: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Middle East and Africa: Antibiotics Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: Middle East and Africa: Antibiotics Market: Breakup by Country (in %), 2021
Figure 102: Middle East and Africa: Antibiotics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 103: Global: Antibiotics Industry: SWOT Analysis
Figure 104: Global: Antibiotics Industry: Value Chain Analysis
Figure 105: Global: Antibiotics Industry: Porter's Five Forces Analysis
